These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12788888)

  • 1. Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
    Anderson RA; Wallace AM; Sattar N; Kumar N; Sundaram K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2784-93. PubMed ID: 12788888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men.
    Anderson RA; Martin CW; Kung AW; Everington D; Pun TC; Tan KC; Bancroft J; Sundaram K; Moo-Young AJ; Baird DT
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3556-62. PubMed ID: 10522995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
    Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
    J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
    Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
    J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone replacement in hypogonadal men.
    Snyder PJ; Peachey H; Berlin JA; Hannoush P; Haddad G; Dlewati A; Santanna J; Loh L; Lenrow DA; Holmes JH; Kapoor SC; Atkinson LE; Strom BL
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception.
    Sundaram K; Kumar N; Bardin CW
    Ann Med; 1993 Apr; 25(2):199-205. PubMed ID: 8489761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men.
    Noé G; Suvisaari J; Martin C; Moo-Young AJ; Sundaram K; Saleh SI; Quintero E; Croxatto HB; Lähteenmäki P
    Hum Reprod; 1999 Sep; 14(9):2200-6. PubMed ID: 10469681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester.
    Behre HM; Nieschlag E
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1204-10. PubMed ID: 1430080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men.
    Suvisaari J; Moo-Young A; Juhakoski A; Elomaa K; Saleh SI; Lähteenmäki P
    Contraception; 1999 Nov; 60(5):299-303. PubMed ID: 10717782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.
    von Eckardstein S; Noe G; Brache V; Nieschlag E; Croxatto H; Alvarez F; Moo-Young A; Sivin I; Kumar N; Small M; Sundaram K;
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5232-9. PubMed ID: 14602755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model.
    Venken K; Boonen S; Van Herck E; Vandenput L; Kumar N; Sitruk-Ware R; Sundaram K; Bouillon R; Vanderschueren D
    Bone; 2005 Apr; 36(4):663-70. PubMed ID: 15784189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception.
    Cummings DE; Kumar N; Bardin CW; Sundaram K; Bremner WJ
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4212-9. PubMed ID: 9851754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic administration of 7alpha-methyl-19-nortestosterone on serum testosterone, number of spermatozoa and fertility in adult male bonnet monkeys (Macaca radiata).
    Ramachandra SG; Ramesh V; Krishnamurthy HN; Kumar N; Sundaram K; Hardy MP; Rao AJ
    Reproduction; 2002 Aug; 124(2):301-9. PubMed ID: 12141943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone.
    Kumar N; Didolkar AK; Monder C; Bardin CW; Sundaram K
    Endocrinology; 1992 Jun; 130(6):3677-83. PubMed ID: 1597164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model.
    Sinnesael M; Callewaert F; Morreels M; Kumar N; Sitruk-Ware R; Van Proeyen K; Hespel P; Boonen S; Claessens F; Vanderschueren D
    Int J Androl; 2011 Dec; 34(6 Pt 2):e601-11. PubMed ID: 21790658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men.
    Suvisaari J; Sundaram K; Noé G; Kumar N; Aguillaume C; Tsong YY; Lähteenmäki P; Bardin CW
    Hum Reprod; 1997 May; 12(5):967-73. PubMed ID: 9194649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 7 alpha-methyl-19-nortestosterone in men and cynomolgus monkeys.
    Kumar N; Suvisaari J; Tsong YY; Aguillaume C; Bardin CW; Lähteenmaki P; Sundaram K
    J Androl; 1997; 18(4):352-8. PubMed ID: 9283946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution, metabolism and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive.
    Prasad PV; Arumugam R; Willman M; Ge RS; Sitruk-Ware R; Kumar N
    Steroids; 2009 Jan; 74(1):121-31. PubMed ID: 18992267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.